Free Daily Technical Summary Reports on Adobe Systems and Three Other Application Software Stocks

Stock Research Monitor: TWOU, MDRX, and AYX

LONDON, UK / ACCESSWIRE / June 27, 2018 / If you want a free Stock Review on ADBE sign up now at www.wallstequities.com/registration. On Tuesday, the NASDAQ Composite ended the day at 7,561.63, up 0.39%; the Dow Jones Industrial Average edged 0.12% higher, to finish at 24,283.11; and the S&P 500 closed at 2,723.06, marginally gaining 0.22%. Gains were broad based as six out of nine sectors finished the trading session in green. WallStEquities.com has initiated research reports on the following Application Software stocks: 2U Inc. (NASDAQ: TWOU), Adobe Systems Inc. (NASDAQ: ADBE), Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX), and Alteryx Inc. (NYSE: AYX). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

2U Inc.

Lanham, Maryland headquartered 2U Inc.’s stock finished Tuesday’s session 1.49% higher at $84.46 with a total trading volume of 574,959 shares. The stock has gained 76.44% in the previous twelve months. The Company’s shares are trading above their 200-day moving average by 13.87%. Moreover, shares of 2U Inc., which operates as an education technology company in the US, Hong Kong, South Africa, and the UK, have a Relative Strength Index (RSI) of 36.18. Get the full research report on TWOU for free by clicking below at:

www.wallstequities.com/registration/?symbol=TWOU

Adobe Systems

Shares in San Jose, California headquartered Adobe Systems Inc. rose 1.07%, ending yesterday’s session at $242.25 with a total trading volume of 2.70 million shares. The stock has gained 13.31% in the previous three months and 67.12% over the past twelve months. The Company’s shares are trading above their 50-day and 200-day moving averages by 1.26% and 21.60%, respectively. Moreover, shares of Adobe Systems, which operates as a diversified software company worldwide, have an RSI of 46.01.

On June 15th, 2018, research firm Stifel reiterated its ‘Buy’ rating on the Company’s stock with an increase of the target price from $250 a share to $275 a share. The free technical report on ADBE can be accessed at:

www.wallstequities.com/registration/?symbol=ADBE

Allscripts Healthcare Solutions

On Tuesday, Chicago, Illinois headquartered Allscripts Healthcare Solutions Inc.’s stock saw a rise of 2.44%, to close the day at $12.17. A total volume of 1.39 million shares was traded. The Company’s shares have advanced 1.67% in the previous three months. The stock is trading below its 50-day moving average by 1.76%. Additionally, shares of the Company, which provides information technology solutions and services to healthcare organizations in the US, Canada, and internationally, have an RSI of 45.02. Sign up for free on Wall St. Equities and claim the latest report on MDRX at:

www.wallstequities.com/registration/?symbol=MDRX

Alteryx

Shares in Irvine, California headquartered Alteryx Inc. ended the day 3.53% higher at $36.93. A total volume of 483,795 shares was traded. The stock has gained 13.67% in the last month and 82.46% over the last twelve months. The Company’s shares are trading above their 50-day and 200-day moving averages by 5.44% and 26.94. Furthermore, shares of Alteryx, which operates a self-service data analytics software platform that enables organizations to enhance business outcomes and the productivity of their business analysts, have an RSI of 51.80.

On June 22nd, 2018, research firm Oppenheimer initiated an ‘Outperform’ rating on the Company’s stock. See the free research coverage on AYX at:

www.wallstequities.com/registration/?symbol=AYX

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 503850